USFDA concludes inspection at Zydus’ LiqMeds in U.K. with four observations
The inspection was conducted from November 9-13, the company said in a regulatory filing to stock exchanges

Read at The Hindu(opens in a new tab)
Full coverage
USFDA concludes inspection at Zydus’ LiqMeds in U.K. with four observations (opens The Hindu in a new tab)
The inspection was conducted from November 9-13, the company said in a regulatory filing to stock exchanges